Patent · US Expired

1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them

US6770649B2 · kind B2 · utility

1Cited by

0References

12Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Daniel Jasserand · Paris, FR
Ulf Preuschoff · Laatzen, DE
Jochen Antel · Annaberg-Buchholz, DE
Samuel David · Dorval, CA
Holger Sann · Hannover, DE
Reinhard Brueckner · Hannover, DE
Dania Birte REICHE · Bingen, DE
Christian Eeckhout · Winsen (Aller), DE

Key dates

Filing date	Sep 13, 2002
Grant date	Aug 3, 2004
Priority date	—
Expiry date	Sep 19, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D407/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds which are antagonistic to tachykinin receptors, of the general formula I, wherein R6, R7, A and Z have the meanings given in the description, and pharmaceutical compositions containing these compounds, as well as a process for the preparation of such compounds and intermediate products of this process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.